======= PHOX2B ======= == Gene Information == * **Official Symbol**: PHOX2B * **Official Name**: paired like homeobox 2B * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=8929|8929]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q99453|Q99453]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PHOX2B&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PHOX2B|Open PubMed]] * **OMIM**: [[https://omim.org/entry/603851|Open OMIM]] == Function Summary == * **Entrez Summary**: The DNA-associated protein encoded by this gene is a member of the paired family of homeobox proteins localized to the nucleus. The protein functions as a transcription factor involved in the development of several major noradrenergic neuron populations and the determination of neurotransmitter phenotype. The gene product is linked to enhancement of second messenger-mediated activation of the dopamine beta-hydroylase, c-fos promoters and several enhancers, including cyclic amp-response element and serum-response element. Expansion of a 20 amino acid polyalanine tract in this protein by 5-13 aa has been associated with congenital central hypoventilation syndrome. [provided by RefSeq, Jul 2016]. * **UniProt Summary**: Involved in the development of several major noradrenergic neuron populations, including the locus coeruleus. Transcription factor which could determine a neurotransmitter phenotype in vertebrates. Enhances second-messenger-mediated activation of the dopamine beta-hydrolase and c-fos promoters, and of several enhancers including cAMP-response element and serum- response element. |Homeobox| |efferent axon development in a lateral line nerve| |retrotrapezoid nucleus neuron differentiation| |retrotrapezoid nucleus development| |medullary reticular formation development| |lateral line nerve development| |lateral line system development| |medulla oblongata development| |noradrenergic neuron development| |hindbrain tangential cell migration| |neural crest cell migration involved in autonomic nervous system development| |brainstem development| |noradrenergic neuron differentiation| |sympathetic ganglion development| |enteric nervous system development| |regulation of respiratory gaseous exchange by nervous system process| |cell migration in hindbrain| |regulation of respiratory system process| |ganglion development| |cell differentiation in hindbrain| |parasympathetic nervous system development| |sympathetic nervous system development| |regulation of respiratory gaseous exchange| |negative regulation of cell cycle arrest| |positive regulation of G2/M transition of mitotic cell cycle| |positive regulation of cell cycle G2/M phase transition| |dopaminergic neuron differentiation| |central nervous system neuron axonogenesis| |autonomic nervous system development| |skeletal muscle cell differentiation| |cranial nerve development| |neural crest cell migration| |neural nucleus development| |positive regulation of mitotic cell cycle phase transition| |nerve development| |neural crest cell development| |central nervous system neuron development| |mesenchymal cell development| |stem cell development| |neural crest cell differentiation| |positive regulation of cell cycle phase transition| |positive regulation of cold-induced thermogenesis| |cellular response to BMP stimulus| |response to BMP| |regulation of cell cycle arrest| |neuron migration| |skeletal muscle tissue development| |skeletal muscle organ development| |regulation of cold-induced thermogenesis| |positive regulation of mitotic cell cycle| |hindbrain development| |mesenchymal cell differentiation| |stem cell differentiation| |glial cell differentiation| |ameboidal-type cell migration| |central nervous system neuron differentiation| |inner ear development| |regulation of G2/M transition of mitotic cell cycle| |respiratory system development| |regulation of cell cycle G2/M phase transition| |gliogenesis| |mesenchyme development| |ear development| |negative regulation of neuron differentiation| |nuclear chromatin| |striated muscle tissue development| |positive regulation of cell cycle process| |negative regulation of neurogenesis| |muscle organ development| |muscle tissue development| |negative regulation of nervous system development| |RNA polymerase II regulatory region sequence-specific DNA binding| |negative regulation of cell cycle process| |negative regulation of cell development| |positive regulation of neuron differentiation| |sensory system development| |axonogenesis| |positive regulation of cell cycle| |axon development| |regulation of mitotic cell cycle phase transition| |cell morphogenesis involved in neuron differentiation| |regulation of cell cycle phase transition| |DNA-binding transcription activator activity, RNA polymerase II-specific| |positive regulation of neurogenesis| |muscle structure development| |neuron projection morphogenesis| |plasma membrane bounded cell projection morphogenesis| |cell projection morphogenesis| |cellular response to growth factor stimulus| |RNA polymerase II proximal promoter sequence-specific DNA binding| |cell part morphogenesis| |response to growth factor| |positive regulation of nervous system development| |positive regulation of cell development| |sensory organ development| |cell morphogenesis involved in differentiation| |negative regulation of cell cycle| |regulation of system process| |regulation of mitotic cell cycle| |regulation of neuron differentiation| |neuron projection development| |negative regulation of cell population proliferation| |negative regulation of cell differentiation| |cell morphogenesis| |brain development| |regulation of cell cycle process| |head development| |neuron development| |regulation of neurogenesis| |cellular component morphogenesis| |regulation of nervous system development| |regulation of cell development| |negative regulation of developmental process| |cell migration| |positive regulation of cell differentiation| |central nervous system development| |neuron differentiation| |cell motility| |localization of cell| |plasma membrane bounded cell projection organization| |cell projection organization| |regulation of cell cycle| |negative regulation of multicellular organismal process| |positive regulation of transcription by RNA polymerase II| |cellular response to endogenous stimulus| |locomotion| |positive regulation of developmental process| |nervous system process| |response to endogenous stimulus| |generation of neurons| |positive regulation of transcription, DNA-templated| |movement of cell or subcellular component| |DNA-binding transcription factor activity, RNA polymerase II-specific| |regulation of cell population proliferation| |neurogenesis| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |cell development| |positive regulation of RNA metabolic process| |positive regulation of multicellular organismal process| |tissue development| |regulation of cell differentiation| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |system process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === No hits were found. No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 12891 * **Expression level (log2 read counts)**: -2.96 {{:chemogenomics:nalm6 dist.png?nolink |}}